I don’t think proteomics will win over genomics," Sanghera said. "They go hand-in-glove. We’ve been overly focused [on genomics], and now we’re going to see an emergence of proteomics. And when the ...
The gene responsible for this disease is in a particularly challenging region of the genome -- it can't be characterized with short read sequencing technology, and the current clinical test is ...